FIGURE 1. Percentage of emergency department visits for nonfatal crash injuries among motor vehicle occupants that result in hospitalization, by age group — National Electronic Injury Surveillance System, United States, 2012  The figure above is a bar chart showing the percentage of emergency department visits for nonfatal crash injuries among motor vehicle occupants that result in hospitalization, by age... |
[Click here to see the rest of this post]
| Relatives of the first person to die of Ebola in the United States, joined by the Rev. Jesse L. Jackson Sr., continued on Saturday to denounce the treatment he and his family had received from a hospital here and from Texas officials, claiming that he had been cremated without their knowledge or permission and given substandard care because he was African. Josephus Weeks, a nephew of the Ebola victim — Thomas Eric Duncan, 42, a Liberian who died Wednesday at the Dallas hospital where he had been found to have Ebola on Sept. 30 — said his uncle had been “handled poorly, unfairly, and an injustice was done.” Mr. Weeks spoke to reporters on Saturday in Chicago with Mr. Jackson and Mr. Duncan’s mother, Nowai Gartay. They asked why Mr. Duncan had not been taken to Nebraska Medical Center, where two Americans who contracted the disease in West Africa have been treated. And they said the Dallas hospital, Texas Health Presbyterian, had not immediately informed them that Mr. Duncan had died and had led them to believe that he was still alive. “I feel bad about my son,” Ms. Gartay said inside a chapel at the Chicago headquarters of Mr. Jackson’s Rainbow/PUSH Coalition. “We call the hospital — they know that my son died, and they didn’t tell me. They only told me, ‘You can’t talk to your son.’ ” Mr. Jackson said the other Ebola victims in the United States “came back to... |
| Infectious diseases are compensable conditions under most state workers' compensation laws. Todays post is shared from northjersey.com An NBC news crew that was worked alongside an Ebola-stricken cameraman in Liberia has been placed under mandatory quarantine through Oct. 22, New Jersey health officials announced Saturday. The state Department of Health issued the order Friday evening, after a voluntary 21-day isolation agreement was violated by the crew, according to a notice posted on the health department's Web site. The notice stressed that the crew remains "symptom-free" and that there was "no reason for concern of exposure to the community." Neither health officials nor an NBC News spokesperson would say who violated the order, how many people were being quarantined or locate where the quarantine was being carried out. But Princeton Police Chief Nicholas Sutter confirmed that his agency, in conjunction with the Princeton Health Department, was enforcing the order. He believed three people, all in Princeton, had been quarantined. He referred all other comment to the state Health Department. The NBC team was led by Chief Medical Editor Nancy Snyderman, who lives in Princeton, according to her bio on the NBC News website. Freelancer Ashoka Mukpo, 33, contracted Ebola while working as a camera operator for Snyderman's team in Liberia, where the virus has killed more than 2,000 people, according to NBC News. He is being treated in Nebraska, where... |
The new daily pill Harvoni costs $94,500 for 12 weeks and $63,000 for eight weeks — both cheaper than some existing hepatitis C treatments, according to the drugmaker. But some patient advocates are already upset about the price after nearly revolting against Gilead’s first hepatitis C therapy, Sovaldi, which became the best-selling new drug ever when it hit the market late last year at $84,000 for 12 weeks. Harvoni, which combines Sovaldi and a new drug called ledipasvir, is expected to push Gilead’s overall hepatitis C drug sales to $12 billion this year and more than $15 billion next year, said Michael Yee, a biotechnology analyst at RBC Capital Markets. “It is a major breakthrough to have yet another regimen that takes two drugs and combines it into one, and shortens the treatment of care for patients,” he said. Debates over cost Sales of Sovaldi were $2.3 billion in the first quarter and $3.5 billion in the second, putting it on track to become one of the world’s best-selling medicines. At the same time, its... |
